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Abstract
Consumption of sugar has been relatively high in the Nordic countries; the impact of sugar intake on
metabolic risk factors and related diseases has been debated. The objectives were to assess the effect of sugar
intake (sugar-sweetened beverages, sucrose and fructose) on association with type 2 diabetes, cardiovascular
disease and related metabolic risk factors (impaired glucose tolerance, insulin sensitivity, dyslipidemia, blood
pressure, uric acid, inflammation markers), and on all-cause mortality, through a systematic review of
prospective cohort studies and randomised controlled intervention studies published between January 2000
and search dates. The methods adopted were as follows: the first search was run in PubMed in October 2010.
A second search with uric acid as risk marker was run in April 2011. The total search strategy was rerun in
April 2011 in SveMed. An update was run in PubMed in January 2012. Two authors independently selected
studies for inclusion from the 2,743 abstracts according to predefined eligibility criteria. The outcome was
that out of the 17 studies extracted, 15 were prospective cohort studies and two were randomised controlled
crossover trials. All of the studies included only adults. With respect to incident type 2 diabetes (nine studies),
four of six prospective cohort studies found a significant positive association for sugar-sweetened beverage
intake. In general, larger cohort studies with longer follow-up more often reported positive associations, and
BMI seemed to mediate part of the increased risk. For other metabolic or cardiovascular risk factors or
outcomes, too few studies have been published to draw conclusions. In conclusion, data from prospective
cohort studies published in the years 20002011 suggest that sugar-sweetened beverages probably increase the
risk of type 2 diabetes. For related metabolic risk factors, cardiovascular disease or all-cause mortality and
other types of sugars, too few studies were available to draw conclusions.
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T
he present literature review is a part of the fifth
version of the Nordic Nutrition Recommenda-
tions (NNR) project with the aim of reviewing and
updating the scientific basis of the fourth edition of the
NNR issued in 2004 (1). The NNR5 project is mainly
focused on a revision of those areas in which new
scientific knowledge has emerged since the fourth edition,
with special relevance for the Nordic setting. A number of
systematic literature reviews will form the basis for
establishment of dietary reference values in the fifth
edition of NNR.
The present expert group was to systematically review
studies regarding carbohydrate quantity and quality in
association with health outcomes. To limit the scope, the
group first reviewed the Dietary Guidelines from the
United States Department of Agriculture (USDA) (24)
and the Dietary Reference Values from European Food
Safety Agency (EFSA) (5), both published in 2010,
especially with respect to how values from those reports
differ from each other and from the NNR 2004. The
dietary reference values from EFSA (5) and the dietary
guidelines from USDA (3, 4), which are partly based on a
(page number not for citation purpose)
Review Article
Food & Nutrition Research 2012. # 2012 Emily Sonestedt et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution-
Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium,
provided the original work is properly cited.
1
Citation: Food & Nutrition Research 2012. 56: 19104 - http://dx.doi.org/10.3402/fnr.v56i0.19104
series of literature reviews, and the NNR from 2004 (1)
are similar with respect to total intake of carbohydrates
(4560E%, 4565E% and 5060E%, respectively) and
fibre for adults (25, 2535 and 2535 g/day, respectively).
Neither the opinion from EFSA nor the report from
USDA found sufficient evidence to support the role of
the glycaemic index and glycaemic load in maintaining
weight and preventing metabolically related diseases
in healthy adults. However, dietary reference values and
guidelines for sugars are not consistent. The NNR from
2004 recommends limiting refined sugar intake to no
more than 10% of total energy intake (E%), whereas
EFSAs Scientific Opinion on Dietary Reference Values
states that the scientific data are insufficient to define an
upper limit and USDA Dietary Guidelines Advisory
Committee suggests a maximal added sugar intake of
25% or less of total energy (3). In contrast, the USDA
policy document recommends that combined added
sugar and solid fat intake be limited to 515E% (4).
The basis for the recommendation of maximum 10E%
from refined sugars in the NNR from 2004 is mainly
based on association with caries in the oral cavity and
lower nutrient density of the food with increasing sugar
intake in the Nordic countries. In recent years, however,
interest has been revived in the potential role of sugar-
sweetened beverages, added sugar and total fructose
intake in the development of metabolic and cardiovas-
cular diseases and risk factors (611), but whether sugar
plays a causal role is still much debated (8, 11). This issue
was not approached in detail in the previous NNR (1).
Sugar consumption has increased dramatically in
the world, including the Nordic countries, over the
last decades; the increase in sugar intake from sugar-
sweetened beverages has been especially prominent (6).
The increase has been more pronounced among older
children, adolescents and young people. In the Nordic
countries, the mean intake of refined sugar was approxi-
mately 812E% in 19972009 (1216). At the same
time the prevalence of obesity and type 2 diabetes has
increased dramatically in the Nordic countries.
We chose to focus on sugar intake in relation to disease
development because of the relatively high sugar intake in
Nordic countries and the discrepancy in recommenda-
tions. Because the World Health Organisation is perform-
ing a systematic literature review on sugar and obesity,
and because a systematic review was previously per-
formed in association with the USDA recommendations
(2), this endpoint was not included in the search.
The aim of this systematic literature review was to
assess the effect of sugar intake (sugar-sweetened bev-
erages, sucrose and fructose) on association with type 2
diabetes, cardiovascular disease and related metabolic
risk factors (impaired glucose tolerance, insulin sensitiv-
ity, dyslipidemia, blood pressure, uric acid, inflammation
markers), and all-cause mortality, through a systematic
review of prospective cohort studies and randomised
controlled intervention studies published in 20002010.
Methods
Eligibility criteria
We defined the literature search and criteria for inclusion
and exclusion (set prior to abstract screening) based on
the following aspects:
(1) Exposure/intervention: We included sugar-sweetened
beverages, sugars, sucrose and fructose as indicators
of dietary sugar exposure. We included studies
examining intrinsic, added and total sugar intake.
(2) Study design: Prospective observational studies
(cohort or nested casecontrol) with a length of
follow up of 4 years or more, or randomised and
controlled interventions that last at least 4 weeks
were included. For randomised studies, the drop-out
rate had to be less than 50%. Studies including more
than one intervention in the experimental arm were
not included.
(3) Outcome: We included cardiovascular disease, type 2
diabetes and all-cause mortality as outcome mea-
sures. Glucose tolerance, insulin sensitivity, serum
lipids, inflammation markers and blood pressure
were chosen as intermediate markers. After scanning
the abstracts, we found that there were several
papers including uric acid, a potentially important
metabolic and cardiovascular risk factor. This
search term was therefore included as an additional
outcome.
(4) Control: The control diet in intervention trials had
to include replacement of sugars with a correspond-
ing amount of carbohydrate. In the case of fructose,
the control group had to include a corresponding
amount of sucrose, glucose or non-sugar carbohy-
drate. Studies not including a control group were not
considered.
(5) Population: The population was defined as the
general healthy population including all age groups.
We also considered studies that included individuals
that were overweight. We only included studies in
humans.
(6) Language: English or a Nordic language.
(7) Article type: Original articles and systematic reviews.
(8) Time period: Main search from January 2000 to
October 2010. Later updated to include November
2010 through December 2011.
Search methods and terms
The literature search was performed in collaboration with
a librarian in order to ensure objectivity. Search terms are
presented in Appendix 1. The first search was run in
October 2010 in Medline through the PubMed platform,
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supplied by United States National Library of Medicine
(http://www.ncbi.nlm.nih.gov/pubmed). Papers from Jan-
uary 2000 to October 2010 were included. An additional
search was done including uric acid as an outcome
(April 2011) with the search terms ‘Uric acid’ (Mesh)
and Uric* (Title/Abstract). In this search the time limits
were slightly changed to include articles from January
2000 to April 2011. Furthermore, in April 2011 the
whole search was rerun in a second database, SveMed,
supplied by the Karolinska Institute in Sweden (http://
micr.kib.ki.se/) (April 2011), in order to include multiple
databases in the systematic literature review. An update
was run in Medline through the PubMed platform in
January 2012 for the time period October 2010 through
December 2011 to identify articles that would change the
conclusion from the search until October 2010.
Selection of articles
After receiving the list of abstracts, two groups of two
experts reviewed the same abstracts independently. The
four experts individually reported to the librarian the
articles to order in full text. Relevant systematic reviews
and meta-analyses were also requested to ensure that all
relevant studies were included in this systematic review.
A paper was ordered in full text if one of the experts
chose to include the paper. Abstracts not relevant for
the research questions were excluded and reasons
given. Papers from other sources were also ordered
from the librarian after going through abstracts, full
text papers and literature lists. The full text papers
were again reviewed by two independent experts. The
experts jointly decided which articles to include. The
excluded articles were listed with reasons for exclusion
(Appendix 2).
Quality assessment and grading of evidence
To assess study quality of the included studies, Quality
Assessment Tools with a number of questions regarding
several aspects of the study (including study design,
population characteristics, exposure measure and out-
come measures) were used (17). Two experts assessed the
quality of the same studies independently and potential
disagreement between experts was discussed in the whole
group. The quality was assessed for all included studies
and ranged from A to C (18). After the quality assess-
ment of individual studies, the results of the quality
assessment were summarised to evaluate the quality
and strength of the evidence in relation to the research
questions posed. The evidence for each outcome was
categorised according to the directions given by the
NNR5 committee guidelines into three categories:
convincing, probable, limited-suggestive and limited-no
conclusion.
Results
Description of studies
The original search resulted in 2,614 abstracts (Fig. 1).
Together with the search for uric acid (68 abstracts) and
the search in the SveMed database (61 abstracts), a
total of 2,743 abstracts were identified. From these
sources 85 abstracts (72 from original search, 9 from
uric acid search and 4 from SveMed search) were
selected for further consideration. From systematic re-
views and other sources we identified four other articles
to order in full text. Out of these, 17 articles (14 from the
original search, 1 from the uric acid search and 2 from
other sources) met the inclusion criteria and were
included in this literature review (Tables 1 and 2). None
of the included studies reached the highest level of
quality (A). The majority of the 17 identified studies
were prospective observational studies (n15). All of the
studies included adults only; none of the studies included
children or adolescents.
In the additional search (November 2010December
2011), including 545 abstracts, 4 papers met the inclusion
criteria and were considered of interest. These papers did
not change the conclusion and were therefore not quality
assessed or included in the paper.
Association between exposure and outcome measures
Blood lipids, glucose and insulin
Two prospective observational studies investigated the
association between consumption of sugar-sweetened
beverages and incident dyslipidemia (19, 20). Both
studies found a positive association with high triglycer-
ides (Table 3), as well as with low LDL cholesterol in the
study including this endpoint (20). However, one of the
Fig. 1. Results of the search.
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Table 1. Description of included prospective cohort studies.
Reference Cohort, country
No. of
participants Age, gender Exposure Diet method Outcome Follow-up
Confounder
adjustments Quality
Bomback
et al. (33)
Atherosclerosis Risk in
Communities (ARIC),
USA
9,451 Mean age:
5254 y,
men
and women
Sugar-sweetened
soft drinks
Semi-quantitative
FFQ
Hyperuricemia 3 y Age, sex, BMI, sodium intake,
caloric intake, hypertension,
diabetes, tobacco and alcohol
use, education, field centre
and race
B
de Koning
et al. (28)
Health Professionals
follow-up Study, USA
40,389 4075 y,
men
Sugar-sweetened
beverages
Semi-quantitative
FFQ
Type 2 diabetes 20 y Age, smoking, physical activity,
alcohol intake, multivitamin
use, family history of type 2
diabetes, high TG at baseline,
high blood pressure, use of
diuretics, weight change,
adherence to a low calorie diet
in 1994, the alternative
healthy eating index, energy
intake
B
Dhingra
et al. (19)
Framingham Heart
Study, USA
6,039 person-
observations
Mean age:
53 y, 57%
women
Soft drinks (both
regular and diet)
Physician-
administered
questionnaire
Metabolic syndrome and
individual components
(waist, fasting glucose,
blood pressure, fasting TG,
HDL-C)
4 y Baseline levels of
metabolic syndrome
component, age, sex, physical
activity, smoking, saturated fat,
trans fat, fiber, magnesium,
total calories, glycaemic index
B
Duffey
et al. (20)
CARDIA, USA up to 2,639 1830 y,
5366%
women
Sugar-sweetened
beverages (sugar-
sweetened soda and
fruit drinks)
Semi-quantitative
interviewer-
administered
diet history FFQ
Blood pressure, fasting
lipids, glucose and insulin
20 y Race, age, sex, weight,
smoking, physical activity,
calories from food,
calories from other
beverages, calories from
alcohol, center
B
Forman
et al. (23)
Nurses Health Study I,
II, Health Professionals
Follow up study, USA
NHS1: 88,540;
NHS2: 97,315;
HPFS: 37,37
Age, women
and men
Fructose Semi-quantitative
FFQ administered
at baseline and
every 4 y
Hypertension NHS1: 20 y;
NHS2: 14 y;
HPFS: 18 y.
Age, BMI, physical activity,
smoking, family history of
hypertension, intake of
alcohol, caffeine, folate and
vitamin C
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Table 1 (Continued)
Reference Cohort, country
No. of
participants Age, gender Exposure Diet method Outcome Follow-up
Confounder
adjustments Quality
Fung
et al. (34)
Nurses Health Study,
USA
88,520 3459 y,
women
Sugar-sweetened soda
and fruit drinks
Semi-quantitative
FFQ administered
at baseline and
every 4 y
Coronary heart disease 24 y Age, smoking, alcohol
intake, family history of
coronary heart disease,
physical activity, aspirin use,
menopausal status,
postmenopausal hormone use,
history of hypertension,
history of high
cholesterol, diet (alternate
healthy eating index)
B
Hodge
et al. (24)
Melbourne
Collaborative Cohort,
Australia
31,276 4069 y,
women and
men
Sugars 121-item FFQ Type 2 diabetes 4 y (baseline
199094)
Age, sex, country of birth,
physical activity, family history
of diabetes,
education, alcohol intake,
previous weight change, BMI,
waist-hip-ratio
C
Janket
et al. (25)
Women’s Health
Study, USA
Mean age:
54 y, women
Total sugars, sucrose,
fructose
semi-quantitative
FFQ
Diabetes 6 y Age, smoking, alcohol
intake, multivitamin use, family
history of diabetes, vigorous
exercise, BMI,
postmenopausal hormone use,
history of hypertension,
history of high
cholesterol
B
Meyer
et al. (26)
Iowa Women’s Health
Study, USA
35,988 5569 y,
women
Sucrose, fructose FFQ Type 2 diabetes 6 y Age, energy intake, BMI,
waist:hip ratio, education,
smoking, alcohol intake and
physical activity
B
Montonen
et al. (27)
Finnish Mobile Clinic
Health Examination
Survey, Finland
4,304 4069 y,
46% women
Total sugars, sucrose,
fructose, soda drinks
Dietary history
interview
(consumption
during previous
year)
Type 2 diabetes 12 y
(baseline
196672)
Age, sex, BMI, energy intake,
smoking,
geographical area, physical
activity, family history of
diabetes and dietary
pattern
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Table 1 (Continued)
Reference Cohort, country
No. of
participants Age, gender Exposure Diet method Outcome Follow-up
Confounder
adjustments Quality
Odegaard
et al. (29)
Singapore Chinese
Health Study, China
43,580 4574 y, 46
59% women
Soft drinks Semi-quantitative
FFQ during
previous year
(face-to-face
interview-based),
eight frequency
and three portion
sizes.
Type 2 diabetes 6 y (baseline
19931998)
Age, sex, dialect, year of
interview, educational
level, smoking status,
alcohol use, physical
activity, saturated fat, dietary
fiber, dairy, juice/soft drink,
coffee BMI and energy intake
B
Paganini-Hill
et al. (35)
Leisure World
Cohort, USA
13,624 44101 y,
63%
women
Sugar-sweetened soft
drinks (cola beverages
with sugar; other soft
drinks with sugar)
FFQ Mortality 23 y
(baseline
1981)
Age, sex, smoking,
exercise, BMI, alcohol,
histories of hypertension,
angina, heart attack, stroke,
diabetes rheumatoid arthritis,
cancer
C
Palmer et al.
(32)
Black Women’s Health
Study, USA
43,960 2169 y,
women
Sugar-sweetened soft
drinks; other fruit
drinks (80% are
sweetened)
FFQ (frequency
and three portion
sizes)
Type 2 diabetes 10 y
(baseline
1995)
Age, family history of
diabetes, physical activity,
cigarette smoking, education,
the other drinks, red meat,
processed meats, cereal fiber,
coffee, glycaemic index
B
Paynter et al.
(31)
Atherosclerosis Risk in
Communities (ARIC),
USA
12,204 4564 y, 56%
women
Sweetened beverages Interview-
administered semi-
quantitative FFQ
Type 2 diabetes 3, 6 or 9 y Study center, age, race,
education, family history of
diabetes, BMI, waist-hip ratio,
energy intake, dietary fiber,
smoking, alcohol
consumption, physical activity
and hypertension
B
Schulze et al.
(30)
Nurses Health Study
II, USA
91,249 2646 y,
women
Sugar-sweetened soft
drinks
Semi-quantitative
FFQ
Type 2 diabetes 8 y (baseline
1991,
updated
1995)
Age, alcohol intake, physical
activity, family history of
diabetes, smoking,
postmenopausal hormone use,
oral contraceptive use, fiber,
magnesium, trans fat, PUFA:
SFA ratio and consumption of
diet soft drinks, fruit juice and
fruit punch
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studies also found a positive association to HDL
cholesterol (19), while the other study found no signifi-
cant association to this marker (20). Furthermore, both
of these studies investigated the association between
sugar-sweetened beverages and incidence of impaired
fasting glucose. One found a positive association (19)
while the other found no association (20) (Table 4).
A 6-week randomised cross-over trial in 12 men and 12
women comparing high fructose vs. glucose intake
(17E%), found adverse effects of the high-fructose diet
on triglyceride concentrations in men but not in women
and on no other marker of blood lipids, i.e. total
cholesterol, LDL cholesterol or HDL cholesterol. Day-
long serum insulin values were lower on the fructose diet
while there was no difference in plasma glucose (21).
In a 6-week randomised cross-over trial in 13 men
comparing high (25E%) vs. moderate (10E%) sucrose
intake in diets otherwise matched for macronutrient and
fibre composition, total cholesterol and LDL cholesterol
concentrations where higher after the high sucrose in-
take, but no difference in concentration of triglycerides or
HDL cholesterol or insulin and glucose were found (22).
Blood pressure
Four studies were identified on the association between
intake of sugars and blood pressure (Table 5). Of the
three prospective cohorts, one found a small increased
risk of hypertension with intake of sugar-sweetened
beverages (20) while the other two, investigating soft
drinks (19) and fructose (23) did not find a significant
association. No significant differences in blood pressure
were found in a 6-week randomised cross-over trial
comparing high (25E%) vs. moderate (10E%) sucrose
intake (22).
Type 2 diabetes
Nine prospective cohort studies were identified for
incidence of type 2 diabetes (Table 6). The results from
the four studies on the association between intake of total
sugars, sucrose or fructose and type 2 diabetes were
inconclusive (2427). Two of three studies found signifi-
cant positive associations with total fructose intake (26,
27). None of the three studies reporting sucrose intake
(2527) and none of the three studies reporting total
sugar intake (24, 25, 27) found a positive association with
incident diabetes; three of them (2426) even found an
inverse association. The six studies reporting on sugar-
sweetened beverages and type 2 diabetes are more
conclusive. Four studies reported a significant increased
relative risk of type 2 diabetes with increasing intake of
sugar-sweetened beverages (2730). Of the two studies
that found no association (31, 32), one study observed a
significant positive association in the model not adjusting
for BMI (32).T
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Other endpoints
No study was identified examining the effect on sugar
consumption on inflammation markers as defined in this
systematic review. One prospective observational study
on consumption of sugar-sweetened soft drinks and uric
acid was identified reporting no association (33) (Table
7). The only study identified on cardiovascular disease,
found a positive association with consumption of sugar-
sweetened beverages (34) (Table 8). Only one prospective
cohort study on mortality was identified (35) (Table 9).
Table 3. Intake of sugars and blood lipids.
Reference Study design Exposure Outcome
No of participants
(incident cases) Effect/association
Bantle
et al. (21)
Randomised
crossover
17E% fructose diet
(14E% added sugar)
vs. glucose diet
(14E% glucose, 3E%
naturally occurring
fructose)
Fasting cholesterol, HDL, TG,
calculated LDL, measured LDL,
apoB, 24 h metabolic profile of
TG
24 Fructose vs. glucose diet:
Cholesterol: 4.30 vs. 4.22, P0.17
LDL: 2.49 vs. 2.49, P0.76
HDL: 1.30 vs. 1.30, P0.97
Plasma TG: in women: 0.93 vs. 0.97,
P0.63; in men: 1.25 vs. 0.95, PB0.001
24 h metabolic profiles of plasma TG:
women: 31 vs. 30 P0.72, men: 46 vs.
35 PB0.001
Black
et al. (22)
Randomised
crossover
25E% sucrose vs.
10E% sucrose diets
total cholesterol, LDL, HDL, TG 13 10E% sucrose vs. 25E% sucrose diet:
Total cholesterol: 4.01 vs. 4.62 pB0.01
LDL 2.25 vs. 2.78 pB0.01
HDL 1.2 vs. 1.2 NS
TG 0.92 vs. 0.95 NS.
Dhingra
et al. (19)
Prospective
cohort
Soft drinks Incidence of hypertriglyceridemia
(]1.7 mmol/L); low HDL
(B1.03 mmol/L)
TG: 6,382 (1,093),
HDL: 5,763 (739)
OR for ]1 servings/day vs. none:
TG:1.25 (1.041.51)
HDL: OR1.32 (1.061.64)
Duffey et al.
(20)
Prospective
cohort
Sugar-sweetened
beverages
High TG (]1.7 mmol/L or
medication); low HDL-C
(B1.04 mmol/L if male and 1.3
mmol/L if female or medication);
high LDL (130 mg/dL or
medication)
TG: 2,627 (542),
HDL: 1,837 (252),
HDL: 2,640 (94)
RR for increase in each exposure
quartile:
TG: 1.06 (1.011.13)
HDL: 1.06 (0.971.16)
LDL: 1.18 (1.021.36)
Table 4. Intake of sugars and glucose tolerance and insulin sensitivity.
Reference Study design Exposure Outcome No of participants Effect/association
Bantle et al.
(21)
Randomised
crossover
17E% fructose diet
(14% added sugar) vs.
glucose diet (14E%
glucose, 3E% naturally
occurring fructose)
Plasma glucose, serum insulin 24 Fructose vs. glucose diet: 24 h metabolic
profiles of plasma glucose: 139 vs. 141,
P0.45; serum insulin 3486 vs. 4243
P0.01
Black et al.
(22)
Randomised
crossover
25E% sucrose vs.
10E% sucrose diets
Plasma glucose, serum insulin,
insulin sensitivity, (two-step
euglycaemichyperinsulinemic
clamp), fasting plasma glucose,
glucose level over 24 h
13 10E% sucrose vs. 25E% sucrose diet:
Interstitial glucose 5.9 vs. 6.1 mmol/L,
NS
Fasting plasma glucose 5.6 vs. 5.6, NS
Fasting serum insulin 8.6 vs. 9.6. NS
Dhingra
et al. (19)
Prospective
cohort
Soft drinks Incidence of impaired fasting
glucose (5.5 mmol/L or
diabetes).
6,459
(1,426 cases)
OR1.25 (1.051.48) for ]1 servings/
day vs. none
Duffey
et al. (20)
Prospective
cohort
Sugar-sweetened
beverages
Incidence of impaired fasting
glucose (6.1 mmol/l or
diabetes medication)
2,160 (267 cases) RR1.03 (0.951.12) moving across
quartiles
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This study found no association between sugar-sweetened
soft drinks and mortality. We are therefore not able to
state anything about the association between sugar intake
and mortality, cardiovascular disease, uric acid or in-
flammation markers.
Reporting and summarising the evidence
Table 10 presents summary of the evidence. The quality
of evidence was graded limited-no conclusions for the
associations between intake of sugars and blood lipids,
sugar intake and glucose tolerance/insulin sensitivity,
sugar intake and blood pressure, sugar intake and uric
acid, sugar intake and incidence of cardiovascular disease
and sugar intake and type 2 diabetes. The quality of
evidence was graded probable for the association between
intake of sugar-sweetened beverages and type 2 diabetes.
Four relevant papers were identified in the last update
until December 2011 (3639). A prospective cohort study
conducted in the Netherlands investigating carbohydrate
quality found no association between intake of total
sugars and incident type 2 diabetes (36). One intervention
study (divided into two papers) investigated the effects of
very-high fructose and very-high glucose diets during 4
weeks, and found no association with insulin sensitivity
(38), while cholesterol and triglycerides were positively
associated with fructose intake (37). One study that
examined the effect of sucrose-sweetened soft drinks
with those of isocaloric milk and non-caloric soft drink
during 6 months found stronger adverse effects for
sucrose-sweetened soft drinks on blood triglycerides and
total cholesterol compared to the other groups (39). As
the results of these studies would not have changed the
overall conclusion of the paper, but further support a
negative role of sugar-sweetened beverages, they were not
included.
Discussion
In this systematic review of prospective cohort studies
and randomised controlled trials published during 2000
2011, data from prospective cohort studies suggest that
sugar-sweetened beverages probably increases the risk of
type 2 diabetes. The results were limited or inconsistent
on the adverse effect of intake of total sugars, glucose or
fructose on the incidence of type 2 diabetes. For other
metabolic and cardiovascular outcomes and mortality,
too few studies were available to draw conclusions.
Four of six prospective cohort studies found a positive
association of sugar-sweetened beverage intake with type
2 diabetes. In general, larger studies more often reported
a significant association. Other systematic reviews of
prospective cohort studies have also found relatively
consistent associations of sugar-sweetened beverages
with type 2 diabetes (40). Part of the risk of sugar-
sweetened beverage intake with incident type 2 diabetes
seems to be mediated by obesity, as suggested by several
of the prospective cohort studies in this systematic review
and by a meta-analysis (40). For example, Palmer et al.
(32) observed that the positive association between sugar-
sweetened beverage intake and type 2 diabetes was no
longer significant in a model adjusting for BMI. Schulze
and co-workers (30) found that, after adjustments for
BMI, the risk estimate for the association between in-
take of sugar-sweetened drinks and type 2 diabetes
was halved, although still significant. Obesity was not
included as an outcome in this systematic review. In
other systematic reviews of prospective studies, sugar-
sweetened beverage intake has been associated with a
higher BMI or obesity in adolescents and adults (41).
Dietary intake of total sugars, sucrose or fructose
was not consistently associated with development of
type 2 diabetes in this systematic review of prospective
Table 5. Intake of sugars and blood pressure.
Reference Study design Exposure Outcome No of participants Effect/association
Black
et al. (22)
Randomised
crossover
25E% sucrose vs.
10E% sucrose diets
Blood pressure 13 10E% sucrose vs. 25E% sucrose diet:
Systolic/diastolic: 125/72 vs. 122/71
(no significant difference)
Dhingra
et al. (19)
Prospective
cohort
Soft drinks Incidence of high BP (135/85
mmHg or medication).
Measured blood pressure
(average of 2 readings)
4,752 (1,004
cases)
OR1.18 (0.961.44) for ]1
servings/day vs. none
Duffey
et al. (20)
Prospective
cohort
Sugar sweetened
beverages
Incidence of high BP (130/85
mmHg or medication)
2,639 (609 cases) RR1.06 (1.011.12) moving across
quartiles
Forman
et al. (23)
Prospective
cohort
Fructose Hypertension (self-reported
clinician-diagnosed)
NHS1: 88,540
(31,107 cases)
NHS2: 97,315
(15,863 cases)
HPFS: 37,375
(11,982 cases)
RR for highest vs. lowest quintiles
NHS: 1.02 (0.991.06)
NHS2: 1.03 (0.981.08)
HPFS: 0.99 (0.931.05)
Sugar intake and health outcomes
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epidemiological evidence published between 2000 and
October 2010. One reason for this might be that a
significant part of the consumed sugars are not added
sugar but naturally occurring sugars in for example fruits.
Studies have not associated intake of fruit in the
recommended quantities with increased risk of type 2
diabetes (42).
For the association between sugar-sweetened beverages
and type 2 diabetes, the dose where the risk of type 2
diabetes increased significantly was at consumption of
two or more servings of sugar-sweetened beverages
per week (29), or at several servings per week or more
(27, 28, 30) in the studies finding a positive associa-
tion. Interestingly, in one of the paper not finding an
Table 6. Association between intake of sugar and incidence of type 2 diabetes.
Reference Exposure Outcome
No of
participants Effect/association
Hodge et al. (24) Sugars (not specified) Type 2 diabetes (self-reported
and confirmed from medical
practitioners)
31,276
(365 cases)
OR for difference between the 87.5th and
12.5th intake percentile: 0.72 (0.560.93),
P0.01
Janket et al. (25) Total sugar, sucrose, fructose Diabetes (self-reported) 38,480
(918 cases)
RR for highest vs. lowest quintile:
Total sugar: 0.77 (0.521.15), P-trend0.26
Sucrose: 0.59 (0.390.88), P-trend0.05
Fructose: 1.24 (0.841.85) P-trend0.30
de Koning
et al. (28)
Sugar sweetened beverages
(caffeinated colas, caffeine-free
colas, other carbonated sugar-
sweetened beverages and non-
carbonated sugar-sweetened
beverages)
Type 2 diabetes (self-reported) 40,389
(2,680 cases)
RR of highest vs. lowest quartile:
1.24 (1.091.40), P-trendB0.01
Meyer et al. (26) Sucrose, fructose Type 2 diabetes 35,988
(1,141 cases)
RR of highest vs. lowest quintile:
Sucrose: 0.81 (0.670.99), P-trend0.027
Fructose: 1.27 (1.061.54), P-trend0.0015
Montonen
et al. (27)
Total sugar; sucrose; fructose;
soda drinks
Type 2 diabetes (from drug
register and medical records)
4,304
(177 cases)
RR of highest vs. lowest quartile:
Total sugars: 1.56 (0.992.46), P-trend0.10
Sucrose: 1.12 (0.711.76), P-trend0.61
Fructose: 1.90 (1.203.01), P-trend0.004
Soft drinks: 1.60 (0.932.76), P-trend0.01
Odegaard
et al. (29)
Soft drinks; other fruit and
vegetable juices (80% were
sweetened)
Type 2 diabetes (self-reported
diagnosis and validated through
hospital records and detailed
telephone interview)
43,580
(2,273 cases)
RR for 2 or more drinks/week vs. rarely
consumed:
Soft drinks: 1.34 (1.171.52) P-trend B0.0001
Juice: 1.24 (1.011.53), P-trend0.09
Palmer et al. (32) Sugar sweetened soft drinks;
sweetened fruit drinks
Type 2 diabetes (self-reported;
validated by in 229 subjects by
physician)
43,960
(2,713 cases)
IRR of ]2 drinks/day vs. B1 drink/month:
Soft drinks: 1.05 (0.901.23) (not adjusting for
BMI: 1.24 (1.061.45); P-trend0.002)
Fruit drinks: 1.31 (1.131.52); P-trend0.001
Paynter
et al. (31)
Sweetened beverage (fruit
punch, non-diet soda, orange
or grapefruit juice)
Type 2 diabetes 12,204
(1,437 cases)
HR of 2 or more/day vs. less than 1 drink/day:
Men: 1.03 (0.821.28), P-trend0.94
Women: 1.01 (0.791.29), P-trend0.58
Schulze
et al. (30)
Sugar-sweetened soft drinks Type 2 diabetes (self-reported;
98% were confirmed by medical
record review in substudies)
91,249
(741 cases)
RR of ]1 drink/day vs. B1/month:
1.39 (1.071.76), P-trend0.01
Table 7. Intake of sugars and uric acid.
Reference Study design Exposure Outcome No of participants Effect/association
Bomback
et al. (33)
Prospective
cohort
Sugar-sweetened
soft drinks
Hyperuricemia (5.7 mg/dl
for women, 7.0 mg/dl for men)
9,451 (3,288 cases) OR for 1 vs.
B1 soda/day: 1.17 (0.951.43)
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association they compared one can per day or less with
two cans or more a day (31). This might be too small of a
difference in sugar-sweetened beverage intake, and it is
clearly different from the other studies that compare
the high consumers (1 or 2 cans) with those not
consuming sugar-sweetened beverages or only rarely or
use lowest compared to highest quartiles. This discre-
pancy in dietary studies has been discussed in papers
pointing at the need to use a different approach when
evaluating evidence-based medicine and evidence-based
nutrition (43).
In observational studies, the sugar intake might be a
marker of other dietary and lifestyle characteristics also
associated with sugar intake. Most of the prospective
cohort studies used validated semi-quantitative FFQs to
assess dietary intakes. Although useful for epidemiologi-
cal studies, these dietary assessment methods are often
imprecise and prone to bias. Most of the observational
cohort studies attempted to control for potential bias and
confounding by adjustment for energy, other dietary
factors, BMI, lifestyle factors and other variables in the
multivariable analyses, but some residual confounding
may remain. In addition, adjustments were made for BMI
in some papers while others did not do this. The duration
of the follow up period among the prospective cohort
studies varied widely, from 4 to 24 years. It might be
considered whether a follow up period of more than 10
years is too long as the diet may change during this
period. For several of the prospective cohort studies, this
was dealt with by repeated assessment of diet at varying
frequencies during the follow-up.
The quality of evidence regarding the relation between
sugar-sweetened beverages and risk of type 2 diabetes
based on the prospective cohort studies was graded
probable, meaning that the evidence is strong enough to
support a judgement of a probable relationship. There
are, according to the NNR systematic literature review
manual, four criteria required for this grade. First, there
must be evidence from at least two independent cohort
studies. This review includes four prospective cohort
studies showing a positive association. Second, there
should be no substantial unexplained heterogeneity
between or within study types of an association, or the
direction of effect. Third, several of the studies need
to be of good quality (graded A or B). All of the four
prospective cohorts were graded B. Fourth, a biological
plausibility of the observed association might be found.
Some researchers have postulated that sugar-sweetened
beverages, or calories consumed as beverages, have
smaller effects on satiety, resulting in higher energy intake
and more weight gain than with other dietary sources
high in sugars (8, 44, 45). In addition, the frequency of
consumption and the amount absorbed at any given time
has been discussed (6, 810, 46). However, it cannot be
excluded that the association of sugar-sweetened bev-
erages is mediated by factors other than sugars. Increased
fructose intake has been postulated as another biological
mechanism explaining the increased risk for diabetes
associated with sugar-sweetened beverage intake. Both
sucrose (50% fructose) and high-fructose corn syrup
(55% fructose), frequently used to sweeten soft drinks,
contain similar amounts of fructose and glucose. Relative
to glucose, fructose may increase liver triacylglycerol
formation, fatty liver, visceral adiposity and insulin
resistance (46). Nonetheless, the current evidence in
humans indicating that high-fructose sweeteners have
more adverse metabolic effects than sucrose on insulin
resistance, fat distribution and other metabolic outcomes
is limited or at best, suggestive.
Surprisingly, medium-to-long term randomised con-
trolled trials on the metabolic effects of fructose, glucose
and sucrose intake meeting the eligibility criteria were
largely lacking. In addition, the trials included had rather
few subjects. Six other intervention studies on sugar
Table 8. Intake of sugars and incidence of cardiovascular disease.
Reference Study design Exposure Outcome
No of
participants Effect/association
Fung
et al. (34)
Prospective
cohort
Sugar-sweetened
soda and fruit drinks
Incident coronary heart disease (reported with
subsequent confirmation by medical records)
88,520
(3,105 cases)
RR for ]2/day vs. B1/month:
1.35 (1.071.69)
Table 9. Intake of sugars and incidence of mortality.
Reference Study design Exposure No of participants Effect/association
Paganini-Hill et al. (35) Prospective
cohort
Cola with sugar; other soft
drinks with sugar
13,624 (11,386 cases) RR for 1 cans/week vs. none:
Cola with sugar: 1.02 (0.921.13)
Other soft drinks with sugar: 1.03
(0.921.16)
Sugar intake and health outcomes
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intake were excluded because of not having an appro-
priate control group. Overall, the findings suggest that
fructose-sweetened beverage intake may have more ad-
verse effects than glucose-sweetened beverage intake.
Also, high sucrose intake may increase LDL cholesterol
levels, but data are limited and in part inconsistent, and
do not allow conclusions to be drawn. In a matched
double-blind parallel-arm trial in 32 middle-aged over-
weight and obese men and women found adverse effects
of 10 weeks of fructose beverage intake on visceral
adiposity, insulin sensitivity and dyslipidemia (47). This
study, although well carried out, carefully controlled and
otherwise meeting eligibility criteria, was not included in
this review because it was not randomised.
Extending the time frame for the systematic review to
the 1980s for example would increase the number of
studies. However, earlier reviews (6, 11) indicate that trial
evidence on high fructose or sucrose intake on metabolic
outcomes in the medium and long-term are inconsistent.
A number of these are reviewed in the EFSA opinion on
carbohydrates.
The heterogeneity in study designs and the problems
induced by the composition of the diets could lead to
discrepancies in results. For example, there may be
Table 10. Summary table on the association between intake of sugars and outcomes.
Outcome Exposure
Number of
participants (studies)
Association/
effect
Number of studies
rated as A, B, C
Strength of
evidence
Type 2 diabetes Sugar-sweetened
beverages
Cohorts: 235,666 (6) Positive (4) or NS (2) 6 rated B Probable
Type 2 diabetes Total sugars Cohorts: 74,405 (3) Inverse (1) or NS (2) 2 rated B, 1 rated C Limited-no conclusion
Type 2 diabetes Sucrose Cohorts: 78,752 (3) Inverse (2) or NS (1) 3 rated B Limited-no conclusion
Type 2 diabetes Fructose Cohorts: 78,752 (3) Positive (2) or NS (1) 2 rated B, 1 rated C Limited-no conclusion
Cardiovascular disease Sugar-sweetened
beverages
Cohorts: 88,520 (1) Positive 1 rated B Limited-no conclusion
Total mortality Sugar-sweetened
beverages
Cohorts: 13,978 (1) NS 1 rated C Limited-no conclusion
Eight Glucose intolerance or
insulin resistance
Sugar-sweetened
beverages
Cohorts: 8,619 (2) Cohorts: Positive (1)
or NS (1)
2 rated B Limited-no conclusion
Glucose intolerance or insulin
resistance
Sucrose Interventions: 13 (1) NS 1 rated B Limited-no conclusion
Glucose intolerance or insulin
resistance
Fructose Interventions: 24 (1) Inverse 1 rated B Limited-no conclusion
Blood pressure Sugar-sweetened
beverages
Cohorts: 7,391 (2) Cohorts: Positive (1)
or NS (1)
3 rated B Limited-no conclusion
Interventions: 32 (1) Interventions: NS
Blood pressure Sucrose Interventions: 13 (1) NS 1 rated B Limited-no conclusion
Blood pressure Fructose Interventions: 24 (1) NS 1 rated B Limited-no conclusion
Cholesterol Sucrose Interventions: 13 (1) Positive 1 rated B Limited-no conclusion
Cholesterol Fructose Interventions: 24 (1) NS 1 rated B Limited-no conclusion
Triglycerides Sugar-sweetened
beverages
Cohorts: 9,009 (2) Positive (2) 2 rated B Limited-no conclusion
Triglycerides Sucrose Interventions: 13 (1) NS 1 rated B Limited-no conclusion
Triglycerides Fructose Interventions: 24 (1) Positive in men, NS in
women
1 rated B Limited-no conclusion
LDL Sugar-sweetened
beverages
Cohorts: 2,640 (1) Positive 1 rated B Limited-no conclusion
LDL Sucrose Interventions: 13 (1) Positive 1 rated B Limited-no conclusion
LDL Fructose Interventions: 24 (1) NS 1 rated B Limited-no conclusion
HDL Sugar-sweetened
beverages
Cohorts: 7,600 (2) Inverse (1) or NS (1) 2 rated B Limited-no conclusion
HDL Sucrose Interventions: 13 (1) NS 1 rated B Limited-no conclusion
HDL Fructose Interventions: 24 (1) NS 1 rated B Limited-no conclusion
Hyperuricemia Sugar-sweetened
beverages
Cohorts: 9,451 (1) NS 1 rated B Limited-no conclusion
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differences in effects of added sugars in intervention
studies in relation to the background diet. Regarding
observational studies, we only included prospective
studies. Many studies have examined the cross-sectional
associations between sugar intake and risk markers and
diseases. However, these studies are an even weaker
measure of causality than prospective cohort studies
(11). Furthermore, there is always a risk of publication
bias as research with significant findings is more likely to
get published.
This review focused on individuals that were consid-
ered generally healthy at baseline. However, it cannot be
excluded that intake of sugars especially in individuals at
risk might have more negative effect than the same
amount in a healthy individual (11).
The recent reports from USDA and EFSA arrived at
different conclusions in their evidence based approach
regarding dietary added sugars. As our systematic review
also suggests, data supporting an association of high
intake of total sugars, sucrose or fructose with adverse
health outcomes is only suggestive, and data for specific
cut-offs is even more limited. A recent review found no
evidence of adverse effects of normal dietary consumption
of fructose on triglyceride concentrations or body weight
in healthy, normal weight individuals (48). However, the
USDA dietary guidelines take a more pragmatic, but less
evidence-based approach. Because the epidemic of obesity
is in simplistic terms based on excessive energy intake
coupled with insufficient energy expenditure, the USDA
recommended limiting energy intake from added sugars
and saturated fat to no more than 15E%. This
is also based on dietary surveys indicating that dietary
added sugar contribute to a large part of the energy
intake in the US population overall, and many of the
most commonly consumed foods in the US population
were high in added sugar with little nutrient value
otherwise (3, 4). In the Nordic countries, intake of
refined sugars is approximately 818E% depending on
age, and marked segments of the population consume at
least 20E%. Given the growing obesity epidemic and
excess energy intake relative to energy expenditure also in
Nordic countries, limiting added sugars also in Nordic
countries might be one target for decreasing energy
intake.
Conclusion
Data from prospective cohort studies published during
2000 to December 2011 suggest that sugar-sweetened
beverages probably increase the risk of type 2 diabetes.
For other metabolic and cardiovascular outcomes, or
other sources of sugars, too few prospective cohort
studies were available to draw conclusions. Evidence
from medium and long-term studies on the metabolic
effects of high-fructose or high sucrose intake is also too
limited to draw conclusions. Although only one of the
studies included in this systematic review is actually
conducted in a Nordic setting, the Finnish Mobile Clinic
Health Examination Survey with baseline 19661972, we
feel that the results can reasonably be transferred to the
Nordic setting. The exposure range in most of the studies
is similar to the Nordic setting, and most were conducted
in cohorts of mainly well-educated individuals with
largely European background. Overall, specific cut-offs
for sugar intake based on strong scientific evidence
cannot be made (5), but pragmatic interpretation of the
evidence as was done by the USDA (3) would support
limiting added sugars and sugar-sweetened beverage
intake to, e.g. 10E% as recommended in the NNR4.
Specific recommendations regarding sugar-sweetened
beverage intake in particular may be warranted.
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Appendix 1. Search terms with regard to exposure, outcome and study design
Exposure Outcome Study design
‘‘Fructose’’[Mesh] OR Glucose tolerance and insulin sensitivity ‘‘Randomized Controlled Trial’’
[Publication Type] OR
‘‘Sucrose’’[Mesh] OR ‘‘Hyperglycemia’’[Mesh] OR randomized[Title/Abstract] OR
‘‘Dietary Sucrose’’[Mesh] OR ‘‘Glucose Intolerance’’[Mesh] OR ‘‘randomized clinical trial’’[Title/Abstract] OR
‘‘sugar sweetened drinks’’
[Title/Abstract] OR
‘‘Blood Glucose’’[Mesh] OR ‘‘Cohort Studies’’[Mesh] OR
soft drink*[Title/Abstract] OR ‘‘impaired fasting glucose’’[Title/Abstract] OR ‘‘Prospective Studies’’[Mesh] OR
refined sugar*[Title/Abstract] OR ‘‘high fasting glucose’’[Title/Abstract] OR ‘‘Epidemiologic Studies’’[Mesh] OR
Sugar*[Title/Abstract] ‘‘fasting plasma glucose’’[Title/Abstract] OR controlled[Title/Abstract] OR
‘‘Hemoglobin A’’[Mesh] OR cohort[Title/Abstract] OR
‘‘Hemoglobin A, Glycosylated’’[Mesh] OR prospective[Title/Abstract] OR
‘‘glycosylated’’[Title/Abstract] OR observational[Title/Abstract] OR
‘‘Insulin Resistance’’[Mesh] OR risk[Title/Abstract] OR
‘‘Hyperinsulinism’’[Mesh] OR incidence[Title/Abstract] OR
‘‘hyperinsulinemia’’[Title/Abstract] OR incident[Title/Abstract] OR
‘‘insulin sensitivity’’[Title/Abstract] OR ‘‘Risk Factors’’[Mesh]
Insulin [Title/Abstract] OR
Serum lipids
‘‘Lipoproteins’’[Mesh] OR
‘‘Lipoproteins, HDL’’[Mesh] OR
‘‘Lipoproteins, LDL’’[Mesh] OR
‘‘Triglycerides’’[Mesh] OR
‘‘Cholesterol’’[Mesh] OR
‘‘serum lipids’’[Title/Abstract] OR
Low density lipoprotein* [Title/Abstract] OR
High density lipoprotein* [Title/Abstract] OR
AND LDL [Title/Abstract] OR AND
HDL [Title/Abstract] OR
Inflammation markers
‘‘Inflammation Mediators’’[Mesh] OR
‘‘Inflammation’’[Mesh] OR
‘‘C-Reactive Protein’’[Mesh] OR
‘‘Leukocyte Count’’[Mesh] OR
Blood pressure
‘‘Blood pressure’’[Mesh] OR
‘‘Hypertension’’[Mesh] OR
Uric acid
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Exposure Outcome Study design
‘‘Uric acid’’[Mesh] OR
Uric*[Title/Abstract] OR
Type 2 diabetes
‘‘diabetes’’[Title/Abstract] OR
‘‘Diabetes Mellitus’’[Mesh] OR
‘‘Diabetes Mellitus, Type 2’’[Mesh] OR
Cardiovascular disease
‘‘Cardiovascular Diseases’’[Mesh] OR
‘‘Myocardial Ischemia’’[Mesh] OR
‘‘Myocardial Infarction’’[Mesh] OR
‘‘Stroke’’[Mesh] OR
‘‘Coronary Disease’’[Mesh] OR
All-cause mortality
‘‘Mortality’’[Mesh] OR
‘‘Survival’’[Mesh] OR
‘‘Fatal Outcome’’[Mesh] OR
‘‘Cause of Death’’[Mesh]
Appendix 2. Exclusion criteria for ordered articles
Article Reason for exclusion
[No authors listed] (2000). ‘‘Side effects. Metformin for blood sugar problems.’’ TreatmentUpdate 12(7):
56.
Did not examine sugar
Assy, N., et al. (2008). ‘‘Soft drink consumption linked with fatty liver in the absence of traditional
risk factors.’’ Can J Gastroenterol 22(10): 811816.
Cross-sectional study
Berg, C. M., et al. (2008). ‘‘Food patterns and cardiovascular disease risk factors: the Swedish
INTERGENE research program.’’ Am J Clin Nutr 88(2): 289297.
Dietary pattern
Brown, C. M., et al. (2008). ‘‘Fructose ingestion acutely elevates blood pressure in healthy young
humans.’’ Am J Physiol Regul Integr Comp Physiol 294(3): R730737.
Acute effects
Brynes, A. E., et al. (2003). ‘‘A randomised four-intervention crossover study investigating the
effect of carbohydrates on daytime profiles of insulin, glucose, non-esterified fatty acids and
triacylglycerols in middle-aged men.’’ Br J Nutr 89(2): 207218.
Too short (24 days)
Buyken, A. E., et al. (2010). ‘‘Carbohydrate nutrition and inflammatory disease mortality in older
adults.’’ Am J Clin Nutr 92(3): 634643.
Foods high in sugars or refined starch
Charlton, K. E., et al. (2005). ‘‘Micronutrient dilution associated with added sugar intake in elderly
black South African women.’’ Eur J Clin Nutr 59(9): 10301042.
Cross-sectional
Chen, L., et al. (2010). ‘‘Reducing consumption of sugar-sweetened beverages is associated with
reduced blood pressure: a prospective study among United States adults.’’ Circulation 121(22):
23982406.
Too short (18 months followup)
Choi, H. K., et al. (2010). ‘‘Fructose-rich beverages and risk of gout in women.’’ JAMA : the journal
of the American Medical Association 304(20): 22702278.
Gout as endpoint
Cowin, I. S., et al. (2001). ‘‘Associations between dietary intakes and blood cholesterol
concentrations at 31 months.’’ Eur J Clin Nutr 55(1): 3949.
Diet (18 months of age), lipid (31 months)
Culling, K. S., et al. (2009). ‘‘Effects of short-term low- and high-carbohydrate diets on postprandial
metabolism in non-diabetic and diabetic subjects.’’ Nutr Metab Cardiovasc Dis 19(5): 345351.
Too short (3 days)
Curhan, G. C., et al. (2010). ‘‘Sugar-sweetened beverages and chronic disease.’’ Kidney Int 77(7):
569570.
Review (not a systematic review)
Davis, J. N., et al. (2007). ‘‘Associations of dietary sugar and glycemic index with adiposity and
insulin dynamics in overweight Latino youth.’’ Am J Clin Nutr 86(5): 13311338.
Cross-sectional
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Article Reason for exclusion
Davis, J. N., et al. (2007). ‘‘Reduction in added sugar intake and improvement in insulin secretion in
overweight latina adolescents.’’ Metab Syndr Relat Disord 5(2): 183193.
Intervention groups combined, reported
change in sugar consumption used
Davis, J. N., et al. (2005). ‘‘The relation of sugar intake to beta cell function in overweight Latino
children.’’ Am J Clin Nutr 82(5): 10041010.
Cross-sectional study
Dolan, L. C., et al. (2010). ‘‘Evidence-based review on the effect of normal dietary consumption of
fructose on development of hyperlipidemia and obesity in healthy, normal weight individuals.’’
Crit Rev Food Sci Nutr 50(1): 5384.
Review (not a systematic review)
Erkkila, A. T., et al. (2007). ‘‘Moderate increase in dietary sucrose does not influence fasting or
postprandial serum lipids regardless of the presence of apolipoprotein E2 allele in healthy subjects.’’
Eur J Clin Nutr 61(9): 10941101.
No control group
Gohgi, Y., et al. (2005). ‘‘[Risk factors for requiring long-term care among middle-aged and elderly
people].’’ Nippon Koshu Eisei Zasshi 52(3): 226234.
Not in English
Harrington, S. (2008). ‘‘The role of sugar-sweetened beverage consumption in adolescent obesity: a
review of the literature.’’ J Sch Nurs 24(1): 312.
SLR on obesity and Sugar Sweetened
Beverages
Heinig, M., et al. (2006). ‘‘Role of uric acid in hypertension, renal disease, and metabolic syndrome.’’
Cleve Clin J Med 73(12): 10591064.
Review (not a systematic review)
Hofmann, S. M., et al. (2009). ‘‘Dietary sugars: a fat difference.’’ J Clin Invest 119(5): 10891092. Comment on Stanhope
Johnson, R. J., et al. (2009). ‘‘Hypothesis: could excessive fructose intake and uric acid cause type
2 diabetes?’’ Endocr Rev 30(1): 96116.
Review (not a systematic review)
Johnson, R. J., et al. (2007). ‘‘Potential role of sugar (fructose) in the epidemic of hypertension,
obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.’’
Am J Clin Nutr 86(4): 899906.
Review (not a systematic review)
Johnson, R. K., et al. (2009). ‘‘Dietary sugars intake and cardiovascular health: a scientific statement
from the American Heart Association.’’ Circulation 120(11): 10111020.
AHA statement
Kirkwood, L., et al. (2007). ‘‘Effects of advice on dietary intake and/or physical activity on body
composition, blood lipids and insulin resistance following a low-fat, sucrose-containing,
high-carbohydrate, energy-restricted diet.’’ Int J Food Sci Nutr 58(5): 383397.
High carbohydrate, high sugar diet
Knight, J., et al. (2010). ‘‘Metabolism of fructose to oxalate and glycolate.’’ Hormone and metabolic
researchHormon- und StoffwechselforschungHormones et metabolisme 42(12): 868873.
Kidney stone as endpoint
Konstantinova, S. V., et al. (2008). ‘‘Dietary patterns, food groups, and nutrients as predictors of
plasma choline and betaine in middle-aged and elderly men and women.’’ Am J Clin Nutr 88(6):
16631669.
Cross-sectional study
Kopp, W. (2006). ‘‘The atherogenic potential of dietary carbohydrate.’’ Prev Med 42(5): 336-342. Review (not a systematic review)
Lairon, D., et al. (2007). ‘‘Digestible and indigestible carbohydrates: interactions with postprandial
lipid metabolism.’’ J Nutr Biochem 18(4): 217227.
Review (not a systematic review)
Lancaster, K. J., et al. (2006). ‘‘Dietary intake and risk of coronary heart disease differ among ethnic
subgroups of black Americans.’’ J Nutr 136(2): 446451.
Descriptional
Lau, C., et al. (2005). ‘‘Dietary glycemic index, glycemic load, fiber, simple sugars, and insulin
resistance: the Inter99 study.’’ Diabetes Care 28(6): 13971403.
Cross-sectional study
Le, K. A., et al. (2006). ‘‘A 4-wk high-fructose diet alters lipid metabolism without affecting insulin
sensitivity or ectopic lipids in healthy humans.’’ Am J Clin Nutr 84(6): 13741379.
No control group
Le, K. A., et al. (2006). ‘‘Metabolic effects of fructose.’’ Curr Opin Clin Nutr Metab Care 9(4):
469475.
Not a randomized control study or
prospective cohort
Lichtenstein, A. H., et al. (2006). ‘‘Diet and lifestyle recommendations revision 2006: a scientific
statement from the American Heart Association Nutrition Committee.’’ Circulation 114(1): 8296.
American Heart Association statement
Liese, A. D., et al. (2010). ‘‘Food intake patterns associated with carotid artery atherosclerosis in
the Insulin Resistance Atherosclerosis Study.’’ Br J Nutr 103(10): 14711479.
Food intake patterns, not clear exposure
Lim, J. S., et al. (2010). ‘‘The role of fructose in the pathogenesis of NAFLD and the metabolic
syndrome.’’ Nat Rev Gastroenterol Hepatol 7(5): 251264.
Review (not a systematic review)
Malik, V. S., et al. (2010). ‘‘Sugar Sweetened Beverages and Risk of Metabolic Syndrome and
Type 2 Diabetes: A Meta-analysis.’’ Diabetes Care.
A meta-analysis
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Article Reason for exclusion
Marckmann, P., et al. (2000). ‘‘Ad libitum intake of low-fat diets rich in either starchy foods or
sucrose: effects on blood lipids, factor VII coagulant activity, and fibrinogen.’’ Metabolism 49(6):
731735.
No control. Only 2 weeks of exposure,
comparing sugar with fiber and starch.
McNaughton, S. A., et al. (2008). ‘‘Dietary patterns, insulin resistance, and incidence of type 2
diabetes in the Whitehall II Study.’’ Diabetes Care 31(7): 13431348.
Dietary pattern, not clear exposure.
McNaughton, S. A., et al. (2009). ‘‘Food patterns associated with blood lipids are predictive of
coronary heart disease: the Whitehall II study.’’ Br J Nutr 102(4): 619624.
Dietary pattern, not clear exposure.
Michels, K. B., et al. (2002). ‘‘A prospective study of variety of healthy foods and mortality in
women.’’ Int J Epidemiol 31(4): 847854.
Dietary pattern, not clear exposure.
Miller, A., et al. (2008). ‘‘Dietary fructose and the metabolic syndrome.’’ Curr Opin Gastroenterol
24(2): 204209.
Review (not a systematic review)
Mirmiran, P., et al. (2008). ‘‘Effect of nutrition intervention on non-communicable disease risk
factors among Tehranian adults: Tehran Lipid and Glucose Study.’’ Ann Nutr Metab 52(2): 9195.
Many dietary changes made, not only sugar
Montonen, J., et al. (2007). ‘‘Consumption of sweetened beverages and intakes of fructose and
glucose predict type 2 diabetes occurrence.’’ J Nutr 137(6): 14471454.
Mo¨lgaard, C., et al. (2003). ‘‘The impact of sugar on health.’’ Ugeskrift for Laeger 165(44):
42074210.
Review (not a systematic review)
Nakagawa, T., et al. (2005). ‘‘Hypothesis: fructose-induced hyperuricemia as a causal mechanism
for the epidemic of the metabolic syndrome.’’ Nat Clin Pract Nephrol 1(2): 8086.
Review (not a systematic review)
Nandorf, R. (2002). ‘‘Coca-Cola vending-machines in schools are grounding for diabetes among
young people.’’ Lakartidningen 99(43): 4296.
Review (not a systematic review)
Nettleton, J. A., et al. (2009). ‘‘Diet soda intake and risk of incident metabolic syndrome and type 2
diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA).’’ Diabetes Care 32(4): 688694.
Diet soda, not sugar swetened beverages
Noel, S. E., et al. (2009). ‘‘A traditional rice and beans pattern is associated with metabolic
syndrome in Puerto Rican older adults.’’ J Nutr 139(7): 13601367.
Dietary pattern, no clear exposure.
Okuno, M., et al. (2010). ‘‘Palatinose-blended sugar compared with sucrose: different effects on
insulin sensitivity after 12 weeks supplementation in sedentary adults.’’ Int J Food Sci Nutr 61(6):
643651.
No control group. Comparing to palatinose
blended sugar with sugar
Pala, V., et al. (2006). ‘‘Associations between dietary pattern and lifestyle, anthropometry and other
health indicators in the elderly participants of the EPIC-Italy cohort.’’ Nutr Metab Cardiovasc Dis
16(3): 186201.
Dietary pattern, no clear exposure (sweets
and dairy)
Palou, A., et al. (2009). ‘‘On the role and fate of sugars in human nutrition and health. Introduction.’’
Obes Rev 10 Suppl 1: 18.
An overview of many reviews (not a
systematic review)
Pereira, C., et al. (2005). ‘‘Application of cluster analysis in prevention of coronary heart disease.’’
Rev Port Cardiol 24(3): 381394.
Comparing coronary patients (N30)
with healthy controls (N30), no clear
exposure.
Raben, A., et al. (2001). ‘‘Diurnal metabolic profiles after 14 d of an ad libitum high-starch,
high-sucrose, or high-fat diet in normal-weight never-obese and postobese women.’’ Am J Clin
Nutr 73(2): 177189.
No control group, short intervention (14d)
Raben, A., et al. (2002). ‘‘Sucrose compared with artificial sweeteners: different effects on ad
libitum food intake and body weight after 10 wk of supplementation in overweight subjects.’’
The American journal of clinical nutrition 76(4): 721729.
Body weight as endpoint
Ruottinen, S., et al. (2009). ‘‘Carbohydrate intake, serum lipids and apolipoprotein E phenotype
show association in children.’’ Acta Paediatr 98(10): 16671673.
Cross sectional study
Ruxton, C. H., et al. (2010). ‘‘Is sugar consumption detrimental to health? A review of the evidence
19952006.’’ Crit Rev Food Sci Nutr 50(1): 119.
Review (not a systematic review)
Ro¨ssner, S. (2004). ‘‘Diabetes caused by sugar? High intake of soft drinks increases the risk of type 2
diabetes.’’ Lakartidningen 101(49): 3982.
Review (not a systematic review)
Sorensen, L. B., et al. (2005). ‘‘Effect of sucrose on inflammatory markers in overweight humans.’’
Am J Clin Nutr 82(2): 421427.
No control group
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Stanhope, K. L., et al. (2009). ‘‘Fructose consumption: considerations for future research on its
effects on adipose distribution, lipid metabolism, and insulin sensitivity in humans.’’ J Nutr 139(6):
1236S1241S.
Review (not a systematic review)
Stanhope, K. L., et al. (2009). ‘‘Consuming fructose-sweetened, not glucose-sweetened, beverages
increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans.’’
The Journal of clinical investigation 119(5): 13221334.
Matched control, not randomized
Sun, S. Z., et al. (2010). ‘‘Lack of association between dietary fructose and hyperuricemia risk in
adults.’’ Nutr Metab (Lond) 7: 16.
Cross sectional study
Swarbrick, M. M., et al. (2008). ‘‘Consumption of fructose-sweetened beverages for 10 weeks
increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and
obese women.’’ Br J Nutr 100(5): 947952.
No control group
Tappy, L., et al. (2010). ‘‘Fructose and metabolic diseases: New findings, new questions.’’ Nutrition
26(1112): 10441049.
Review (not a systematic review)
Taylor, E. N., et al. (2008). ‘‘Fructose consumption and the risk of kidney stones.’’ Kidney Int 73(2):
207212.
Kidney stones as endpoint
Valensi, P. (2005). ‘‘Hypertension, single sugars and fatty acids.’’ J Hum Hypertens 19 Suppl 3: S59. Review (not a systematic review)
Vasankari, T., et al. (2006). ‘‘Effect of dietary fructose on lipid metabolism, body weight and glucose
tolerance in humans.’’ Scandinavian Journal of Food & Nutrition 50(2): 5563.
Review (not a systematic review)
Ventura, E., et al. (2009). ‘‘Reduction in risk factors for type 2 diabetes mellitus in response to a
low-sugar, high-fiber dietary intervention in overweight Latino adolescents.’’ Arch Pediatr Adolesc
Med 163(4): 320327.
Both low sugar and high fiber I.e., no clear
exposure
Williams, C. L., et al. (2008). ‘‘Childhood diet, overweight, and CVD risk factors: the Healthy Start
project.’’ Prev Cardiol 11(1): 1120.
Only one 24 hour recall
Visvanathan, R., et al. (2005). ‘‘The effects of drinks made from simple sugars on blood pressure in
healthy older people.’’ Br J Nutr 93(5): 575579.
Postprandial measurements
Vogt, J. A., et al. (2006). ‘‘L-rhamnose and lactulose decrease serum triacylglycerols and their rates of
synthesis, but do not affect serum cholesterol concentrations in men.’’ J Nutr 136(8): 21602166.
Intervention using L-rhamnose, Lactulose or
Glucose
Vos, M. B., et al. (2009). ‘‘Fructose and oxidized low-density lipoprotein in pediatric nonalcoholic
fatty liver disease: a pilot study.’’ Arch Pediatr Adolesc Med 163(7): 674675.
Not a healthy population
Yaghoobi, N., et al. (2008). ‘‘Natural honey and cardiovascular risk factors; effects on blood
glucose, cholesterol, triacylglycerole, CRP, and body weight compared with sucrose.’’
ScientificWorldJournal 8: 463469.
Not healthy at baseline
Yoshida, M., et al. (2007). ‘‘Surrogate markers of insulin resistance are associated with
consumption of sugar-sweetened drinks and fruit juice in middle and older-aged adults.’’
J Nutr 137(9): 21212127.
Cross sectional study
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